From: Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG
Variables | Total cohort (n = 1887) | cTnT group (n = 971) | hs-cTnT group (n = 916) | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | P | OR | 95%CI | P | OR | 95%CI | P | |
Age (y) | 1.021 | 0.973–1.071 | 0.403 | 1.001 | 0.924–1.805 | 0.977 | 1.032 | 0.967–1.101 | 0.344 |
Female (n, %) | 1.123 | 0.536–2.353 | 0.758 | 0.883 | 0.296–2.640 | 0.824 | 1.595 | 0.543–4.682 | 0.396 |
NYHA classification (n, %) | 1.540 | 0.936–2.535 | 0.089 | 1.198 | 0.530–2.659 | 0.677 | 1.870 | 0.933–3.749 | 0.078 |
Cerebrovascular disease (n, %) | 0.179 | 0.042–0.774 | 0.021 | 0.202 | 0.044–0.920 | 0.039 | 0.000 | 0.000–0.000 | 0.996 |
Ccr (mL/min/1.73 m2) | 0.995 | 0.977–1.012 | 0.551 | 0.992 | 0.965–1.020 | 0.567 | 1.002 | 0.979–1.026 | 0.851 |
LVEF (%) | 0.959 | 0.977–1.012 | 0.551 | 0.953 | 0.893–1.016 | 0.140 | 0.954 | 0.910–1.000 | 0.049 |
Peripheral vascular disease (n, %) | 3.099 | 0.954–10.066 | 0.060 | 2.176 | 0.398–11.903 | 0.370 | 3.579 | 0.607–21.117 | 0.159 |
Emergency operation (n, %) | 3.256 | 1.115–9.506 | 0.031 | 0.549 | 0.029–10.402 | 0.689 | 5.232 | 1.449–18.885 | 0.012 |
Renal failure (n, %) | 2.016 | 0.443–9.170 | 0.364 | 0.627 | 0.040–9.701 | 0.738 | 5.681 | 0.793–40.713 | 0.084 |
Myocardial injury classification (n, %) | 1.491 | 1.049–2.119 | 0.026 | 2.421 | 1.030–5.689 | 0.042 | 1.761 | 1.102–2.814 | 0.018 |
EuroSCORE II (%) | 1.310 | 1.045–1.643 | 0.019 | 1.544 | 1.015–2.349 | 0.043 | 1.273 | 0.879–1.844 | 0.201 |
Hypertension (n, %) | 0.823 | 0.406–1.669 | 0.589 | 1.889 | 0.502–7.108 | 0.347 | 0.482 | 0.185–1.256 | 0.135 |
Diabetes (n, %) | 1.259 | 0.634–2.498 | 0.511 | 1.709 | 0.653–4.475 | 0.275 | 0.871 | 0.310–2.444 | 0.793 |
Combined valvulardisease (n, %) | 0.388 | 0.125–1.199 | 0.100 | 0.273 | 0.031–2.392 | 0.241 | 0.326 | 0.079–1.345 | 0.121 |
BMI (kg/m2) | 0.996 | 0.884–1.123 | 0.949 | 0.992 | 0.830–1.184 | 0.925 | 0.984 | 0.823–1.176 | 0.859 |